Latest News from: American College of Rheumatology (ACR)

Filters close
8-Nov-2005 10:00 AM EST
Still the Mind, Calm the Rheumatoid Arthritis
American College of Rheumatology (ACR)

Utilizing meditation to reduce stress has shown promise in alleviating some symptoms of rheumatoid arthritis patients.

8-Nov-2005 10:00 AM EST
Aggressive Treatment Reduces Long-Term Costs of RA
American College of Rheumatology (ACR)

While early, aggressive treatment of rheumatoid arthritis can result in increased costs for medications and short-term outpatient services, it substantially improves disease symptoms and, ultimately, reduces long-term medical expenditures for these patients.

8-Nov-2005 10:00 AM EST
Beneficial Osteoporosis Therapy Faces Mental Hurdles
American College of Rheumatology (ACR)

Despite the proven advantages bisphosphonate therapy offers in reducing fractures, complications of dosing are discouraging women with osteoporosis from taking the medication.

8-Nov-2005 10:00 AM EST
Lupus Patients Surviving Longer
American College of Rheumatology (ACR)

The health and survival of patients with lupus has improved significantly over the last three decades, a trend that could be attributed to earlier diagnosis and more aggressive treatment.

8-Nov-2005 10:00 AM EST
Aadalimumab Shows Promise for Anklyosing Spondylitis
American College of Rheumatology (ACR)

Adalimumab, an anti-TNF agent often used in the treatment of rheumatoid arthritis, has been shown to be effective in reducing the signs and symptoms of ankylosing spondylitis.

8-Nov-2005 10:00 AM EST
Continued Use of Anti-TNF Therapy "Pays Off" in Increased Work Force Participation
American College of Rheumatology (ACR)

Continued observation in a long-term study of patients with rheumatoid arthritis shows an increase in work force participation by those using anti-TNF therapy.

8-Nov-2005 10:00 AM EST
New Treatment Shows Promise for Gout
American College of Rheumatology (ACR)

A new treatment called febuxostat, the first new gout treatment in 40 years, may be superior at lowering levels of serum uric acid in patients with gout compared to allopurinol and placebo.

15-Oct-2004 10:00 AM EDT
SERM-Accompanied Teriparatide Offers Improved Bone Therapy for Postmenopausal Patients
American College of Rheumatology (ACR)

The combination of teriparatide (Forteo(t)), an injectable parathryoid hormone medication, when administered with the selective estrogen receptor modulator, raloxifene (Evista (r)), improves bone density formation, according to research.

15-Oct-2004 10:00 AM EDT
Promising Results in Reducing Fracture Risks for Osteoporosis Patients
American College of Rheumatology (ACR)

Strontium ranelate, a new oral medication on the horizon, may reduce spinal, non-spinal, hip and other fractures in older women with osteoporosis, according to research.

15-Oct-2004 10:00 AM EDT
Semi-annual Therapy May Prove Effective in Bone Resorption
American College of Rheumatology (ACR)

A novel treatment administered semiannually to postmenopausal women with low bone density appears to rapidly inhibit the bone resorption process, resulting in improvements in bone mineral density at 12 months, according to research.

15-Oct-2004 10:00 AM EDT
Trial Treatment Results for Children with Severe Arthritis Encouraging
American College of Rheumatology (ACR)

Preliminary results of a one-year study of adalimumab (HUMIRA (tm) ) indicate that this treatment for adults with rheumatoid arthritis also may provide rapid and substantial responses in children with juvenile idiopathic arthritis, according to research.

15-Oct-2004 10:00 AM EDT
DMARDS Show On-Going Benefit in Juvenile Arthritis Patients
American College of Rheumatology (ACR)

Children with juvenile arthritis have long-term improvement in joint pain and swelling when treated with leflunomide or methotrexate, drugs commonly used to treat rheumatoid arthritis in adults, according to research.

15-Oct-2004 10:00 AM EDT
Arthritis Patients Spend Twice as Many Health Care Dollars
American College of Rheumatology (ACR)

The expenses for medical care for those with arthritis are at least double the amount spent by those without this debilitating disease, according to research.

15-Oct-2004 10:00 AM EDT
COX-2 Agents Have Dramatically Changed the NSAID Landscape
American College of Rheumatology (ACR)

COX-2 agents, with their perceived reduction in side effects, have contributed substantially to a dramatic increase in NSAIDs (non-steroidal anti-inflammatory drugs) prescription utilization and influenced the way physicians prescribe rheumatology medication, according to research.

15-Oct-2004 10:00 AM EDT
Pneumococcal Vaccinations Prove Acceptable for Rheumatoid Arthritis Patients
American College of Rheumatology (ACR)

Pneumococcal vaccinations help to protect patients with rheumatoid arthritis against serious pneumococcal infections of the lungs, brain, blood, and ears , according to research.

15-Oct-2004 10:00 AM EDT
Studies Expand Efficacy of Etanercept for Juvenile Arthritis Patients
American College of Rheumatology (ACR)

The efficacy of treatment with etanercept (Enbrel(r)), already credited with rapid clinical improvements sustained for up to two years in patients with juvenile rheumatoid arthritis, has now been extended to as long as four years, according to research.

15-Oct-2004 10:00 AM EDT
Prednisone May Be a High Risk Factor for Pneumonia in Rheumatoid Arthritis Patients
American College of Rheumatology (ACR)

Rheumatoid arthritis patients taking the commonly-prescribed steroid, prednisone, run a significantly higher risk of contracting pneumonia than do those on biologic medications, according to research.

15-Oct-2004 10:00 AM EDT
PPI Treatment Prescription Levels Not Impacted by COX-2 Therapy
American College of Rheumatology (ACR)

Surprisingly, the use of COX-2 therapy does not decrease the number of prescriptions written for ulcer prevention medications such as proton pump inhibitors in patients with rheumatoid arthritis and osteoarthritis, according to research.

15-Oct-2004 10:00 AM EDT
Frequent Knee Pain Points to Increased Incidence of Symptomatic Osteoarthritis
American College of Rheumatology (ACR)

Even when X-rays are normal, knee pain can be due to osteoarthritis, according to research.

15-Oct-2004 10:00 AM EDT
Improved Vitamin D Levels May Decrease Knee Disability in Osteoarthritis Patients
American College of Rheumatology (ACR)

Increased vitamin D levels appear to improve muscle strength and physical function for vitamin D-deficient patients with knee osteoarthritis, according to research.

15-Oct-2004 10:00 AM EDT
Genetics Indicate Propensity Towards Severe Osteoarthritis
American College of Rheumatology (ACR)

Genetics play a stronger role in the development of severe osteoarthritis than environmental factors, according to research.

15-Oct-2004 10:00 AM EDT
Barometric Change and Cooler Temperatures Do Affect Joint Pain
American College of Rheumatology (ACR)

By comparing two sets of independently collected data, experts finally have been able to substantiate that changes in barometric pressure and temperature really do cause aches and pains for arthritis sufferers, according to research.

15-Oct-2004 10:00 AM EDT
Acupuncture Proves Effective as Adjunctive Therapy for Knee Osteoarthritis
American College of Rheumatology (ACR)

Traditional Chinese acupuncture - the use of fine needles inserted into the skin at precise points - in conjunction with medical treatment reduces pain and improves function in patients with knee osteoarthritis, according to research.

15-Oct-2004 10:00 AM EDT
Oral Contraceptive Link to Lupus Flare Severed
American College of Rheumatology (ACR)

Oral contraceptive use does not cause disease flare in patients with systemic lupus erythematosus, or lupus, according to research.

15-Oct-2004 10:00 AM EDT
Risks from Contraceptive Methods Prove Equal for Lupus Patients
American College of Rheumatology (ACR)

The use of combined oral contraceptives, progestin-only oral contraceptives (minipill) and copper intrauterine devices (IUD) appear to produce the same level of risk for disease activity and flares in women with systemic lupus erythematosus, known as lupus, according to research.

15-Oct-2004 10:00 AM EDT
Pulmonary Hypertension Often Goes Undiagnosed in Connective Tissue Disease Patients
American College of Rheumatology (ACR)

Pulmonary hypertension, which is high blood pressure in the lungs, is often not diagnosed in patients with scleroderma and mixed connective tissue disease despite its being a major disease complication and leading cause of death in this patient population, according to research.

15-Oct-2004 10:00 AM EDT
Treatment for Systemic Sclerosis Well Tolerated by Patients in Initial Studies
American College of Rheumatology (ACR)

A new antibody, still under development, that neutralizes transforming growth factor, TGF beta 1, in patients with diffuse cutaneous systemic sclerosis has proven to be well tolerated for the patients who participated in a recent trial, according to research.

15-Oct-2004 10:00 AM EDT
Treatment for Pulmonary Hypertension as a Complication of Lupus, Scleroderma
American College of Rheumatology (ACR)

An investigational new drug for pulmonary hypertension may improve the quality of life for thousands of patients with scleroderma, lupus, and other associated connective tissue diseases, according to research.

15-Oct-2004 10:00 AM EDT
Genetic Link May Play Role in Increased Rheumatoid Arthritis Joint Damage
American College of Rheumatology (ACR)

Rheumatoid arthritis patients with a genetic variation of a protein called TNF (tumor necrosis factor) may experience increased joint damage, according to research.

15-Oct-2004 10:00 AM EDT
Genetic Profiles and Risks of Common Infections for Rheumatoid Arthritis Patients
American College of Rheumatology (ACR)

Identifiable genetic factors may pre-dispose rheumatoid arthritis patients to common infections, according to research.

15-Oct-2004 10:00 AM EDT
TNF Inhibitor Therapy May Increase Risk of Serious Post-operative Infection
American College of Rheumatology (ACR)

TNF inhibitor therapy, which has proven successful in reducing inflammation in patients with rheumatoid arthritis, may increase the risk of serious post-operative infections when taken prior to orthopedic surgery, according to research.

15-Oct-2004 10:00 AM EDT
Infliximab Risk of Serious Infection Equal to Methotrexate
American College of Rheumatology (ACR)

Rheumatoid arthritis patients receiving the recommended starting dose of infliximab have no more serious rate of infections than do patients taking methotrexate alone; however, patients undergoing induction and treatment with a high dose have more problems with infections, according to research

15-Oct-2004 10:00 AM EDT
Long-Term Efficacy, Safety Demonstrated for Rheumatoid Arthritis Treatments
American College of Rheumatology (ACR)

Two studies demonstrating the long term safety and effectiveness of two anti-TNF agents -- etanercept and adalimumab -- in the treatment of rheumatoid arthritis will be presented this week.

Released: 27-Oct-2003 8:30 AM EST
ACR/REF Announce $3 Million Grant from Centocor
American College of Rheumatology (ACR)

The American College of Rheumatology Research and Education Foundation today announced a program designed to encourage research careers in rheumatic medicine. This new program "“ made possible by a $3 million grant from Centocor "“ supports a fellowship program for young physicians.

17-Oct-2003 12:50 PM EDT
Role of Chopstick Use in Developing OA of the Hand
American College of Rheumatology (ACR)

The mechanical stress of chopstick use is associated with prevalent osteoarthritis of the hand, according to research presented this week. The study recruited 2,507 60-year-old residents from random Beijing neighborhoods.

17-Oct-2003 1:00 PM EDT
Compliance with Guidelines Could Reduce Fracture Risk
American College of Rheumatology (ACR)

Despite the availability of medications to decrease the fracture risk that comes with long-term corticosteroid treatment, fracture risk remains elevated, suggesting that preventive treatments are underused.

17-Oct-2003 1:20 PM EDT
Sustained Relief from Back Pain even After Treatment is Stopped
American College of Rheumatology (ACR)

Prevention of back pain in women with osteoporosis can last up to 18 months beyond the end of treatment with teriparatide, a new medication used to treat osteoporosis, according to research presented this week.

17-Oct-2003 2:00 PM EDT
Benefits of Osteoporosis Treatment on Fracture Risk
American College of Rheumatology (ACR)

Reduction in fracture risk from risedronate, a medication commonly used to treat patients who have osteoporosis, is seen even in patients who have only small improvements in bone mass, according to research presented this week.

17-Oct-2003 2:00 PM EDT
Lessons from Industrial Management Applied to Osteoporosis
American College of Rheumatology (ACR)

A successful program to improve rheumatology-based management and coordination of osteoporosis care can serve as a model for other institutions, according to research presented this week.

17-Oct-2003 2:10 PM EDT
New Hope for Children Who Suffer from Juvenile Arthritis
American College of Rheumatology (ACR)

A new treatment may be safe and effective for children who suffer from systemic-onset juvenile idiopathic arthritis, a severe form of arthritis affecting tens of thousands of children, according to research presented this week.

17-Oct-2003 2:20 PM EDT
New Therapy May Help Those with Osteoarthritis of the Knee
American College of Rheumatology (ACR)

The injection of an agent designed to combat rheumatoid arthritis into the knees of patients with osteoarthritis of this joint appears to be safe and may provide relief from pain for days, according to research.

17-Oct-2003 2:30 PM EDT
New Treatment May Become First Line Therapy for Lupus Nephritis
American College of Rheumatology (ACR)

A new treatment was shown to be as effective as a standard treatment with potentially fewer side effects for patients with lupus nephritis, a kidney disorder complication of systemic lupus erythematosus, according to research.

17-Oct-2003 2:40 PM EDT
Bosentan Effectively Treats Painful Ulcer Condition
American College of Rheumatology (ACR)

A new treatment exists for the thousands of people who experience painful and disabling open sores on their hands and toes related to a condition known as systemic sclerosis (scleroderma), according to research.

17-Oct-2003 2:40 PM EDT
Blood Test May Predict Development of Rheumatoid Arthritis
American College of Rheumatology (ACR)

A blood test to determine the presence of certain antibodies may accurately predict the likelihood of developing rheumatoid arthritis in certain people, according to research presented this week.

17-Oct-2003 2:40 PM EDT
Combination Therapy More Effective for People with Early RA
American College of Rheumatology (ACR)

Patients receiving doxycycline plus methotrexate as first line of treatment for rheumatoid arthritis showed greater improvement than patients on methotrexate alone, according to research presented this week.

17-Oct-2003 2:50 PM EDT
New Therapy Effective for Severe Rheumatoid Arthritis
American College of Rheumatology (ACR)

Alefacept plus methotrexate treatment yielded encouraging results for the treatment of severe rheumatoid arthritis, according to research presented this week.

17-Oct-2003 3:00 PM EDT
Hospitalizations for Rheumatoid Arthritis Have Decreased
American College of Rheumatology (ACR)

Hospitalization rates for three severe complications related to rheumatoid arthritis have decreased, which is an indicator that the outcomes associated with the disease are improving, according to research.

17-Oct-2003 3:30 PM EDT
Early Aggressive Treatment for RA May Mean Better Outcomes
American College of Rheumatology (ACR)

People with early stage rheumatoid arthritis should receive aggressive care in order to achieve better outcomes, according to research presented this week.

17-Oct-2003 3:30 PM EDT
Inflammation Marker Predicts Cardiovascular Mortality in Rheumatoid Arthritis
American College of Rheumatology (ACR)

Baseline results of the blood test for C-reactive protein are a good predictor of the risk of death from heart disease in patients with inflammatory polyarthritis, indicating a direct link between C-reactive protein and cardiovascular disease, according to research presented this week.

17-Oct-2003 3:30 PM EDT
Inflammation, Cardiovascular Problems and Rheumatoid Arthritis
American College of Rheumatology (ACR)

Long-term systemic, or widespread, inflammation experienced by patients with rheumatoid arthritis leads to an increased risk of death from cardiovascular disease, according to research presented this week.



close
0.21828